Metropolitan Life Insurance Company (MetLife)’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,377
Closed -$534K 2696
2021
Q4
$534K Buy
21,377
+2,523
+13% +$63.1K 0.01% 1381
2021
Q3
$454K Sell
18,854
-619
-3% -$16.5K 0.01% 1526
2021
Q2
$532K Buy
19,473
+2,217
+13% +$53K 0.01% 1482
2021
Q1
$345K Buy
17,256
+596
+4% +$12K 0.01% 1658
2020
Q4
$311K Sell
16,660
-325
-2% -$5.98K ﹤0.01% 1660
2020
Q3
$294K Buy
16,985
+1,154
+7% +$18.1K 0.01% 1553
2020
Q2
$215K Buy
+15,831
New +$184K ﹤0.01% 1747

Other funds holding VRT

Metropolitan Life Insurance Company (MetLife)'s VRT Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vertiv (VRT) in Q1 2022, closing a stake of 21,377 shares — an estimated $534K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VRT in Q2 2020 and held it in 7 quarters. The position peaked at $534K in Q4 2021. 293 funds tracked by Wall St. Rank hold VRT as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Vertiv position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 21,377 Vertiv shares in Q1 2022, an estimated $534K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Vertiv in Q2 2020 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Vertiv position peaked at $534K in Q4 2021.
  • 293 funds tracked by Wall St. Rank held Vertiv as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.